State GA
Clinical Trials in Georgia
Recruiting clinical trials with at least one study location in Georgia. Data updated daily from ClinicalTrials.gov.
Top Conditions in Georgia
NCT07159633 N/A
Recruiting
OurRelationship-S: A Digital Relationship-Strengthening Program for Couples Expe...
Condition
Relationship Conflict
Enrollment
120 pts
Location
United States
Sponsor
OurRelationship
NCT06418204 N/A
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients T...
Condition
Breast Carcinoma
Enrollment
2,000 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
NCT05919511 N/A
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Condition
cGVHD
Enrollment
1,500 pts
Location
United States
Sponsor
Incyte Corporation
NCT07307664 N/A
Recruiting
Increasing Germline Genetic Testing for Patients With Cancer
Condition
Hereditary Pancreatic Cancer
Enrollment
1,000 pts
Location
United States
Sponsor
Josh Peterson
NCT06735599 N/A
Recruiting
Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pres...
Condition
Hypertension (Without Type 2 Diabetes Mellitus)
Enrollment
40 pts
Location
United States
Sponsor
Georgia State University
NCT06674863 N/A
Recruiting
Addressing Health Literacy With a Tailored Survivorship Care Plan
Condition
Localized Prostate Carcinoma
Enrollment
150 pts
Location
United States
Sponsor
Emory University
NCT05939414 Phase 3
Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Obse...
Condition
Oligometastatic Prostate Cancer (OMPC)
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
NCT05787587 Phase 1
Recruiting
A Study of PARG Inhibitor IDE161 in Participants With Advanced Solid Tumors
Condition
Advanced or Metastatic Solid Tumors
Enrollment
216 pts
Location
United States
Sponsor
IDEAYA Biosciences
NCT05006716 Phase 1, Phase 2
Recruiting
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell M...
Condition
B-cell Malignancy
Enrollment
614 pts
Location
United States, Australia, Brazil
Sponsor
BeOne Medicines
NCT06808984 Phase 2
Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the ...
Condition
Agitation
Enrollment
120 pts
Location
United States
Sponsor
Celgene
NCT04429087 Phase 1
Recruiting
A Study to Test Different Doses of BI 764532 in Patients With Small Cell Lung Ca...
Condition
Patients With Small Cell Lung Carcinoma and Other Neoplasms
Enrollment
300 pts
Location
United States, Germany, Japan
Sponsor
Boehringer Ingelheim
NCT06079671 Phase 3
Recruiting
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (e...
Condition
Locally Advanced Cervical Cancer
Enrollment
800 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
NCT06806592 Phase 3
Recruiting
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to ...
Condition
Interstitial Lung Diseases
Enrollment
400 pts
Location
United States, Australia, Austria
Sponsor
Boehringer Ingelheim
NCT06137144 Phase 1, Phase 2
Recruiting
AZD3470 as Monotherapy and in Combination With Anticancer Agents in Participants...
Condition
Lymphoma
Enrollment
110 pts
Location
United States, Australia, France
Sponsor
AstraZeneca
NCT02402244 N/A
Recruiting
Project: Every Child for Younger Patients With Cancer
Condition
Adrenal Gland Pheochromocytoma
Enrollment
75,000 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT04342429 N/A
Recruiting
Prospective Study of Intensity-Modulated Proton Therapy (IMPT) for Small Cell Lu...
Condition
Small-cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Emory University
NCT06483945 N/A
Recruiting
Dexcom Continuous Glucose Monitoring System Use in aReal-World, Global Registry ...
Condition
Diabetes
Enrollment
5,000 pts
Location
United States
Sponsor
DexCom, Inc.
NCT07143175 N/A
Recruiting
CARE-D-FOOT-Nav Pilot
Condition
Diabetic Foot Ulcer (DFU)
Enrollment
25 pts
Location
United States
Sponsor
Emory University
NCT06823167 Phase 1
Recruiting
A Phase 1 Study of IM-1021 in Participants With Advanced Cancer
Condition
Solid Malignancies
Enrollment
117 pts
Location
United States, Spain
Sponsor
Immunome, Inc.
NCT06995729 Phase 1
Recruiting
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Chi...
Condition
Acute Treatment of Migraine
Enrollment
16 pts
Location
United States
Sponsor
Pfizer
NCT07175428 Phase 2
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Antic...
Condition
Atrial Fibrillation (AF)
Enrollment
1,200 pts
Location
United States, Canada
Sponsor
Regeneron Pharmaceuticals
NCT06533059 Phase 1
Recruiting
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant S...
Condition
Cancer
Enrollment
110 pts
Location
United States, Australia, France
Sponsor
Alterome Therapeutics, Inc.
NCT03339128 Phase 2
Recruiting
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bow...
Condition
Irritable Bowel Syndrome
Enrollment
95 pts
Location
United States, Bulgaria, Canada
Sponsor
AbbVie
NCT02604277 N/A
Recruiting
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
Condition
Depression
Enrollment
130 pts
Location
United States
Sponsor
Emory University
NCT07431853 Phase 2
Recruiting
A Study to Learn About mRNA Vaccines Against Influenza in Adults
Condition
Healthy Adults
Enrollment
770 pts
Location
United States
Sponsor
Pfizer
Page 1 of 12 — 298 trials total